Abstract:Ghrelin is a novel 28-amino acid peptide with an n-octanoyl ester in the serine 3 that has recently been discovered in rat and human gastrointestinal tract, as an endogenous ligand for growth hormone (GH) secretagogue receptor 1. Ghrelin is produced and stored in granules of the special neuroendocrine cells (A-like cells), located mainly in oxyntic mucosa 2. Ghrelin stimulates GH release and induces a positive energy balance by stimulating food intake and decreasing fat use 3. Ghrelin also has numerous peripheral actions including direct effects on exocrine and endocrine pancreatic functions, carbohydrate metabolism, gastric secretion, stomach motility, and sleep 4. Recently, some authors revealed that administration of ghrelin during reperfusion had protective effects on myocardial ischemia reperfusion injury, including reduced ischemic volume, improvements in coronary flow, and attenuation of lipid peroxidation in a rat model 5. But the exact effect of ghrelin on focal cerebral ischemia reperfusion and the mechanism underlying it are still unknown. Focal cerebral ischemia in adult male Sprague-Dawley rats (weighing 250–280 g) was induced by MCAO (middle cerebral artery occlusion) for 90 min with an intraluminal filament according to the method previously described by Longa 6. Rat ghrelin was administered intraperitoneally (160 μg/kg) 30 min before MCAO and at the beginning of reperfusion. Brain samples were obtained 24 h after MCAO. In this study, we demonstrated that systemic administration of ghrelin significantly reduced infarct volumes from MCAO (data shown in Figure 1A). The protective effect of ghrelin on cell apoptosis and neuronal degeneration after ischemia reperfusion injury was evaluated by TUNEL and Fluoro-Jade B staining, a kind of polyanionic fluorescein derivative that specifically bound to degenerating neurons. In ghrelin-treated group, the number of TUNEL-positive cells and degenerating neurons in the peri-infarct area decreased significantly (Figure 1B,C). Given the fact that ghrelin can pass through the blood–brain barrier 7, these findings suggest that peripherally administered ghrelin enters the brain parenchyma and exerts neuroprotective effects on cerebral ischemia reperfusion. The inhibitive effect of ghrelin on apoptosis was supposed to be related to the activation of PI3K/AKT signaling pathway by the phosphoralation of Akt in an endothelial cell injury 8. Reactive oxygen species (ROS) have been implicated in the pathogenesis of cerebral ischemia reperfusion injury 9. These oxygen-free radicals are directly toxic to neurons and initiate a free radical-mediated cascade causing neuronal damage. To assess the effect of ghrelin on ROS, we evaluated the production of superoxide anion, an important reactive oxygen species (ROS) using DHE (dihydroethidium). In this study, we found superoxide anion production was enhanced after reperfusion, and ghrelin treatment could attenuate it (Figure 2). These might be related to the mechanism that ghrelin could inhibit NADPH oxidase activation and reduce ROS production 10. In summary, we have demonstrated that peripheral administration of ghrelin could protect neurons from ischemic injury caused by MCAO. The protective effects of ghrelin appear to be related with an inhibition of apoptosis and oxidative stress. Our results suggest that ghrelin can function as a neuroprotective agent, and administration of ghrelin may be a novel therapeutic strategy for the treatment of ischemic stroke. This study was supported by National Natural Sciences Foundation of China (30801183), Key Clinical Disciplines Program of Chinese Health Ministry and Grants of Health Bureau of Zhejiang Province (2012).

Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways.

Ghrelin Protects H9c2 Cells from Hydrogen Peroxide-Induced Apoptosis Through NF-κB and Mitochondria-Mediated Signaling

Ghrelin Ameliorates Diabetic Retinal Injury: Potential Therapeutic Avenues for Diabetic Retinopathy

Detrimental effect of Ghrelin on hypoxia/reoxygenation- induced injury of H9c2 cells by enhancing cell autophagy

Ghrelin Protects the Myocardium with Hypoxia/reoxygenation Treatment Through Upregulating the Expression of Growth Hormone, Growth Hormone Secretagogue Receptor and Insulin-Like Growth Factor-1, and Promoting the Phosphorylation of Protein Kinase B

Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy

Ghrelin Protects Heart Against ERS-induced Injury and Apoptosis by Activating AMP-activated Protein Kinase

Ghrelin Protects H9c2 Cardiomyocytes from Angiotensin Ii-Induced Apoptosis Through the Endoplasmic Reticulum Stress Pathway

Inhibition of Endoplasm Reticulum Stress by Ghrelin Protects Against Ischemia/reperfusion Injury in Rat Heart.

Ghrelin mediated cardioprotection using in vitro models of oxidative stress

Ghrelin Protects Human Umbilical Vein Endothelial Cells Against High Glucose-Induced Apoptosis Via Mtor/p70s6k Signaling Pathway

GLP-1 Agonist Protects Myocardial Hypoxia-Reoxygenation Injury Through PI3K/ Akt Signaling Pathway: an Experimental Study

Protection of Ghrelin on Adipose-derived Mesenchymal Stem Cells under Hypoxia-reoxygenation Injury

Ghrelin Improves Functional Survival of Engrafted Adipose-Derived Mesenchymal Stem Cells in Ischemic Heart Through PI3K/Akt Signaling Pathway.

Ghrelin Inhibit Cell Apoptosis in Pancreatic Β Cell Line HIT-T15 Via Mitogen-Activated Protein Kinase/phosphoinositide 3-Kinase Pathways

Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway

Glucagon-like peptide-1 attenuates endoplasmic reticulum stress–induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways

Ghrelin Protects Against Palmitic Acid or Lipopolysaccharide-Induced Hepatocyte Apoptosis Through Inhibition of MAPKs/iNOS and Restoration of Akt/eNOS Pathways.

Ghrelin Attenuated Cerebral Ischemia Reperfusion Injury in Rats

Ghrelin contributes to protection of hepatocellular injury induced by ischaemia/reperfusion.

Ghrelin Regulates the Proliferation and Apoptosis of High Glucose‐induced Islet Cells Through the PI3K–Akt Signaling Pathway